161 related articles for article (PubMed ID: 9489331)
21. Somatostatin receptors in meningiomas: a scintigraphic study using 111In-DTPA-D-Phe-1-octreotide.
Maini CL; Tofani A; Sciuto R; Carapella C; Cioffi R; Crecco M
Nucl Med Commun; 1993 Jul; 14(7):550-8. PubMed ID: 8355914
[TBL] [Abstract][Full Text] [Related]
22. [The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
Chiti A; Spinelli A; Bombardieri E
Radiol Med; 1997 Oct; 94(4):362-70. PubMed ID: 9465244
[No Abstract] [Full Text] [Related]
23. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
[TBL] [Abstract][Full Text] [Related]
24. 111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer.
Crippa F; Bombardieri E; Chiti A; Soresi E; Boffi R; Buraggi GL
J Nucl Biol Med (1991); 1994 Dec; 38(4):576-8. PubMed ID: 7786920
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results.
Krenning EP; Kwekkeboom DJ; Oei HY; de Jong RJ; Dop FJ; Reubi JC; Lamberts SW
Ann N Y Acad Sci; 1994 Sep; 733():416-24. PubMed ID: 7978890
[No Abstract] [Full Text] [Related]
26. Detection of extrathoracic manifestations in sarcoidosis with somatostatin analogue scintigraphy.
Eklund A; Jacobsson H; Larsson SA; Sköld CM
Sarcoidosis Vasc Diffuse Lung Dis; 1997 Sep; 14(2):146-51. PubMed ID: 9306505
[TBL] [Abstract][Full Text] [Related]
27. [Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].
Dabasi G; Hauser P; Kertész GP; Balázs G; Karádi Z; Constantin T; Bognár L; Klekner A; Schuler D; Garami M
Magy Onkol; 2007; 51(3):229-34. PubMed ID: 17922063
[TBL] [Abstract][Full Text] [Related]
28. Indium-111 octreotide scintigraphy in neurofibromatosis.
Maini CL; Cioffi RP; Tofani A; Sciuto R; Fontana M; Carapella CM; Crecco M
Eur J Nucl Med; 1995 Mar; 22(3):201-6. PubMed ID: 7789392
[TBL] [Abstract][Full Text] [Related]
29. Intensification of 111In-DTPA-octreotide scintigraphy by means of pretreatment with cold octreotide in small cell lung cancer.
Soresi E; Invernizzi G; Boffi R; Possa M; Bombardieri E; Ciavarella GP; Liuzzi A
Lung Cancer; 1997 Jul; 17(2-3):231-8. PubMed ID: 9237158
[TBL] [Abstract][Full Text] [Related]
30. Identification of the soluble in vivo metabolites of indium-111-diethylenetriaminepentaacetic acid-D-Phe1-octreotide.
Bass LA; Lanahan MV; Duncan JR; Erion JL; Srinivasan A; Schmidt MA; Anderson CJ
Bioconjug Chem; 1998; 9(2):192-200. PubMed ID: 9548534
[TBL] [Abstract][Full Text] [Related]
31. DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy.
Otte A; Jermann E; Behe M; Goetze M; Bucher HC; Roser HW; Heppeler A; Mueller-Brand J; Maecke HR
Eur J Nucl Med; 1997 Jul; 24(7):792-5. PubMed ID: 9211767
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of 111In-octreotide scans in CNS tumors.
Sciuto R; Ferraironi A; Semprebene A; Occhipinti E; Mastrostefano R; Crecco M; Mottolese M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):101-3. PubMed ID: 9002762
[TBL] [Abstract][Full Text] [Related]
33. Metastasis of neuroendocrine colon carcinoma mimicking Graves' ophthalmopathy.
Busse F; Führer D; Stumvoll M; Schneider JP; Neid M; Kluge R; Sterker I
Thyroid; 2008 Nov; 18(11):1237-8. PubMed ID: 18925841
[No Abstract] [Full Text] [Related]
34. New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
Virgolini I; Traub T; Leimer M; Novotny C; Pangerl T; Ofluoglu S; Halvadjieva E; Smith-Jones P; Flores J; Li SR; Angelberger P; Havlik E; Andreae F; Raderer M; Kurtaran A; Niederle B; Dudczak R
Q J Nucl Med; 2000 Mar; 44(1):50-8. PubMed ID: 10932601
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin receptor: scintigraphy and radionuclide therapy.
Krenning EP; Kooij PP; Pauwels S; Breeman WA; Postema PT; De Herder WW; Valkema R; Kwekkeboom DJ
Digestion; 1996; 57 Suppl 1():57-61. PubMed ID: 8813472
[TBL] [Abstract][Full Text] [Related]
36. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
Lastoria S; Vergara E; Palmieri G; Acampa W; Varrella P; Caracò C; Bianco RA; Muto P; Salvatore M
J Nucl Med; 1998 Apr; 39(4):634-9. PubMed ID: 9544670
[TBL] [Abstract][Full Text] [Related]
37. Radiation doses deriving from patients undergoing 111In-DTPA-D-phe-1-octreotide scintigraphy.
Kurtaran A; Pfreitfellner J; Schaffarich P; Smith-Jones P; Niederle B; Raderer M; Virgolini I; Bergmann H; Havlik E
Eur J Nucl Med; 1997 Oct; 24(10):1298-300. PubMed ID: 9323272
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic utility of somatostatin receptor scintigraphy in oncology.
Valkema R; Steens J; Cleton FJ; Pauwels EK
J Cancer Res Clin Oncol; 1996; 122(9):513-32. PubMed ID: 8781566
[TBL] [Abstract][Full Text] [Related]
39. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer.
Soresi E; Bombardieri E; Chiti A; Boffi R; Invernizzi G; Crippa F; Maffioli L
Tumori; 1995; 81(2):125-7. PubMed ID: 7778214
[TBL] [Abstract][Full Text] [Related]
40. The value of octreotide scintigraphy in patients with lung cancer.
Kwekkeboom DJ; Kho GS; Lamberts SW; Reubi JC; Laissue JA; Krenning EP
Eur J Nucl Med; 1994 Oct; 21(10):1106-13. PubMed ID: 7828621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
